| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.001 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |